Protalix Biotherapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.89

-0.02 (-0.69%)

As of Feb 8, 2:03 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +979.9% upside

Low Target $17.92

Average Target $31.21

High Target $31.70

Current Price $2.89

Current
$2.89

Target
$31.21

$17.92 $31.21 avg $31.70

Scenario Analysis

Bear Case

$17.92

520.1%

Low target

Base Case

$31.21

+979.9%

Avg target

Bull Case

$31.70

+996.9%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$26.76

-89.2% from high

52-Week Low

$15.80

+-81.7% from low

Target vs 52W High

$31.21

+16.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%